A B S T R A C T The dihydrotestosterone content of normal peripheral and benign hyperplastic prostates was measured in tissue obtained at open surgical procedures on 29 men of ages 36 to 82 yr. The dihydrotestosterone content in normal prostates (mean±SE, 5.1±0.4 ng/g tissue) and in benign hyperplastic prostates (5.0±0.4) was similar. In 11 patients in whom both normal and hyperplastic prostatic tissue was harvested simultaneously at the same operation, there was no significant difference in the content of dihydrotestosterone in the two types of tissue. These findings fail to confirm the widespread belief that dihydrotestosterone content is elevated in benign hyperplastic prostates. Our data differ from the reported literature in one major respect: the dihydrotestosterone content of normal peripheral prostate in this study is three to four times higher than previously reported. This difference between the present and earlier studies was resolved by experiments performed on cadavers, which were the source of normal prostatic tissue used by other investigators. Dihydrotestosterone content was measured in seven cadavers ranging in age from 19 research into the etiology of BPH has focused on factors that may be responsible for this accumulation of supranormal levels of dihydrotestosterone and the mechanismn by which this induces prostatic hyperplasia. Recently, while investigating the value of dihydrotestosterone content as a marker for the hormonal responsiveness of prostatic cancer, we noted that the content of dihydrotestosterone in normal and benign hyperplastic tissues obtained at open surgical procedures was similar. In reviewing the literature to determine why we were unable to confirm the findings of others, we learned that the "elevated" levels of dihydrotestosterone in BPH which were reported by others were based upon measurements performed on surgically removed specimens, whereas the "low levels" of dihydrotestosterone in normal tissue were based upon measurements performed on tissues obtained at autopsy (4-8). This observation suggested that the conditions of tissue harvesting may have significantly influenced the endogenous levels of androgens within the prostate. To explore this possibility, the present study was undertaken. Dihydrotestosterone content in normal and benign hyperplastic tissue has been measured in tissues removed at open surgical procedures and at autopsy on men of varying ages. These data suggest that the dihydrotestosterone content of prostatic tissue removed at autopsy is abnormally low. This finding was confirmed by in vitro incubations of prostatic tissue at 37°C that demonstrated rapid disappearance of dihydrotestosterone. These data indicate that when prostatic tissue is harvested appropriately, the dihydrotestosterone content of normal peripheral and hyperplastic tissues is the same. This finding should influence future research into the etiology of BPH. carcinoma of the prostate (eight patients), and radical cystoprostatectomy for the treatment of carcinoma of the bladder (15 patients). Seven additional prostates were removed at autopsy from men who ranged in age from 19 to 82 yr. The bodies were brought to the morgue and refrigerated within 4 h of death. The average time from death to removal of the prostate was 14 h (range 4.5-17 h). Normal testicular volumes were documented in all autopsied patients. After removal, all prostatic tissue was placed immediately in iced saline and examined by a surgical pathologist. Those specimens that were found to be hyperplastic were dissected into hyperplastic and normal peripheral segments. The tissue was then rinsed in iced saline, weighed, and stored in liquid nitrogen. A representative segment of each specimen was placed in formalin and later analyzed by the surgical pathologist to confirm the histological diagnosis.
A B S T R A C T The dihydrotestosterone content of normal peripheral and benign hyperplastic prostates was measured in tissue obtained at open surgical procedures on 29 men of ages 36 to 82 yr. The dihydrotestosterone content in normal prostates (mean±SE, 5.1±0.4 ng/g tissue) and in benign hyperplastic prostates (5.0±0.4) was similar. In 11 patients in whom both normal and hyperplastic prostatic tissue was harvested simultaneously at the same operation, there was no significant difference in the content of dihydrotestosterone in the two types of tissue. These findings fail to confirm the widespread belief that dihydrotestosterone content is elevated in benign hyperplastic prostates. Our data differ from the reported literature in one major respect: the dihydrotestosterone content of normal peripheral prostate in this study is three to four times higher than previously reported. This difference between the present and earlier studies was resolved by experiments performed on cadavers, which were the source of normal prostatic tissue used by other investigators. Dihydrotestosterone content was measured in seven cadavers ranging in age from 19 to 82 yr of age. The results of this experiment indicate that the dihydrotestosterone content of prostatic tissue removed at autopsy is factitiously low (0.7-1.0 ng/g tissue). This finding was confirmed by in vitro incubations of fresh prostatic tissue at 37°C that demonstrated reduction of dihydrotestosterone content to low levels within 2 h. When taken together, these results indicate that when prostatic tissue is harvested appropriately, the dihydrotestosterone content of normal peripheral and hyperplastic tissues is the same. This INTRODUCTION Dihydrotestosterone is the major intracellular androgenic metabolite within the prostate (1, 2) . Recognizing the central regulatory role of dihydrotestosterone in growth of the prostate, Wilson and co-workers (3) first suggested that dihydrotestosterone accumulation might be implicated in the etiology of benign prostatic hyperplasia (BPH).' This suggestion was based initially on an investigation of several different animal species to determine whether the capacity of the prostate to form dihydrotestosterone could be correlated with prostatic growth (3) . Their study demonstrated that, in most animals, the prostate loses its ability to form dihydrotestosterone with age. However, in two animal species, the dog and man, high rates of dihydrotestosterone formation persist throughout life. Because these are the two animal species that spontaneously develop prostatic hyperplasia, they proposed that BPH might be the result of the unregulated production of dihydrotestosterone over many yers. To explore this possibility further, Siiteri and Wilson (4) measured the androgen content in normal and hyperplastic human prostates. Although they found no significant difference in the content of testosterone in the two types of tissue, the content of dihydrotestosterone was three-to fourfold greater in hyperplastic tissue than in normal glands. Subsequently, this observation has been confirmed by other investigators (5) (6) (7) (8) , and for the past dozen years, research into the etiology of BPH has focused on factors that may be responsible for this accumulation of supranormal levels of dihydrotestosterone and the mechanismn by which this induces prostatic hyperplasia.
Recently, while investigating the value of dihydrotestosterone content as a marker for the hormonal responsiveness of prostatic cancer, we noted that the content of dihydrotestosterone in normal and benign hyperplastic tissues obtained at open surgical procedures was similar. In reviewing the literature to determine why we were unable to confirm the findings of others, we learned that the "elevated" levels of dihydrotestosterone in BPH which were reported by others were based upon measurements performed on surgically removed specimens, whereas the "low levels" of dihydrotestosterone in normal tissue were based upon measurements performed on tissues obtained at autopsy (4) (5) (6) (7) (8) . This observation suggested that the conditions of tissue harvesting may have significantly influenced the endogenous levels of androgens within the prostate. To explore this possibility, the present study was undertaken. Dihydrotestosterone content in normal and benign hyperplastic tissue has been measured in tissues removed at open surgical procedures and at autopsy on men of varying ages. These data suggest that the dihydrotestosterone content of prostatic tissue removed at autopsy is abnormally low. This finding was confirmed by in vitro incubations of prostatic tissue at 37°C that demonstrated rapid disappearance of dihydrotestosterone. These data indicate that when prostatic tissue is harvested appropriately, the dihydrotestosterone content of normal peripheral and hyperplastic tissues is the same. This finding should influence future research into the etiology of BPH. 4 h of death. The average time from death to removal of the prostate was 14 h (range 4.5-17 h). Normal testicular volumes were documented in all autopsied patients. After removal, all prostatic tissue was placed immediately in iced saline and examined by a surgical pathologist. Those specimens that were found to be hyperplastic were dissected into hyperplastic and normal peripheral segments. The tissue was then rinsed in iced saline, weighed, and stored in liquid nitrogen. A representative segment of each specimen was placed in formalin and later analyzed by the surgical pathologist to confirm the histological diagnosis.
METHODS
Homogenization. The tissue frozen in liquid nitrogen was pulverized with a Thermovac tissue pulverizer (RediIndustries Corp., Copiague, NY). The powdered tissue was added to 10 vol buffer (10 mM Tris, 1.5 mM EDTA, and 10% [wt/vol] glycerol, pH 7.4, at 22°C) and homogenized in an all glass Duall homogenizer (Kontes Co., Vineland, NJ) for three 5-10-s periods (pestle speed, 1,350 rpm) with a 60-s 4°C cooling-off period in between. An aliquot (0.5 ml) was saved for DNA determination, which was measured by the method of Burton (9) by using calf thymus DNA as standard. Results were expressed as nanograms of steroid per gram tissue or per milligrams of DNA±SE. The data were analyzed statistically by the t test (10) or the Wilcoxon rank sum test (1 1).
Extraction and defatting.
[3H]Testosterone (2,000 dpm; 3 pg) and [3H]dihydrotestosterone (2,000 dpm; 5 pg) were added to each extraction tube for recovery measurement.
Each sample was then extracted three times with 5 ml of ethyl ether (12) . Each sample was defatted by passing the residue of the ether extract through a Bond-Elut column (octadecyl-C18; 200 mg Sorbent) obtained from Analytical International Inc. The columns were first washed with 2 vol each of methanol, acetonitrile, and water. The residue of the ether extract was dissolved in 1 ml of water, which was added to the column. The steroids were eluted from the column with 3 ml of acetonitrile into a 12 X 75-mm collection tube and dried under nitrogen in a water bath at 45°C.
HPLC purification of testosterone and dihydrotestosterone. Testosterone and dihydrotestosterone in the defatted ether extracts of prostatic tissue were purified with a Waters Associates (Milford, MA) 6,000 A liquid chromatograph equipped with a Whatman Chemical Separation, Inc. (Clifton, NJ) Partasil ODS-3 column (4.6 mm X 25 cm). The steroids were eluted from the column with acetonitrile:water (50:50, vol/vol) at a flow rate of 3 ml/min. Testosterone, 5a-androstane-3a,17,B-diol, dihydrotestosterone, and androsterone eluted from the column at 3.2-3.8, 4.0-4.6, 4.8-5.6, and 7.0-7.8 min, respectively. Eluates of testosterone and dihydrotestosterone were aliquoted for radioimmunoassay and for a recovery estimation via liquid scintillation spectrometry.
Radioimmunoassay. The radioimmunoassay procedures used were identical to those described elsewhere (12) .
Validation of the assay. The defatting procedure removed material from the tissue extract that interfered with the radioimmunoassay of testosterone and dihydrotestosterone. 5a-androstan-3a,17jB-diol, and androsterone were eluted separately from dihyrotestosterone in the HPLC system, and therefore did not interfere with the dihydrotestosterone assay. (Fig. 1) . Both normal peripheral and benign hyperplastic tissue were removed simultaneously at the same operation in the 11 patients who are listed in Tables I and II . When the dihydro- testosterone content in these specimens was compared, there was no significant difference (11) between the levels in normal peripheral and benign hyperplastic tissue (Table III) . Thus, these results fail to support the prior observations of others which suggest that the dihydrotestosterone content of benign hyperplastic tissue is elevated above normal levels (4) (5) (6) (7) (8) . In an effort to reconcile this difference, we reviewed the reports of others and learned that the levels of dihydrotestosterone in hyperplastic tissue reported herein correlated closely with those reported previously (4-6 ng/g tissue) (4-8, 13). However, the levels of dihydrotestosterone in normal peripheral prostate reported by others (1. earlier studies demonstrated that when BPH tissue, which was surgically removed, was incubated at room temperature for 4-12 h and then refrigerated for another 8-16 h, there was no significant decrease in dihydrotestosterone content (4, 14) . However, the unclothed body of an adult in an environmental temperature of 60°F only cools at 1°F/h during the first 3 h after death, and then at 2°F/h during the next 3 h (15) . If the body is clothed, the rate of cooling is 66% slower. (16) . These facts indicated the need to determine the influence of incubations performed at 370C on dihydrotestosterone content. Normal peripheral and hyperplastic prostatic tissue obtained from a patient undergoing radical cystoprostatectomy was divided into 150-mg aliquots. A sample was frozen immediately and the remainder of the tissue was incubated at 370C for intervals up to 4 h (Fig. 2) . By 1 h, the content of dihydrotestosterone in normal and (Fig. 2) .
DISCUSSION
The major finding in this study is that the content of dihydrotestosterone in normal prostatic tissue is similar to the content in the hyperplastic gland. The dihydrotestosterone content in normal prostatic tissue has been studied previously by six different laboratories (Table V) . In five of the six reports, the measurements on normal tissue were performed on specimens obtained at autopsy and in these cases, dihydrotestosterone content was low (1.3-2.1 ng/g tissue) (4) (5) (6) (7) (8) 13 (19) . However, as the secretory capacity of the prostate diminishes, the gland continues to grow and histologic changes of BPH become more evident. These data suggest that factors that regulate growth of the canine prostate and at least one differentiated function (i.e., secretion) may be controlled separately; also, the fact that abnormal growth continues in the face of declining dihydrotestosterone levels suggests that regulatory factors other than dihydrotestosterone may be involved in the etiology of the hyperplastic growth of the dog prostate. The recognition that human BPH occurs in the presence of normal tissue levels of dihydrotestosterone should focus research efforts to identify other factors that may sensitize this tissue and accelerate growth.
